Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional

Study of Alternate Formulation of Aripiprazole in Agitated Patients With Schizophrenic Disorders

ClinicalTrials.gov ID: NCT00036127

Public ClinicalTrials.gov record NCT00036127. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 9:28 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Study to learn if the alternate formulation is effective in agitated schizophrenic patients

Study identification

NCT ID
NCT00036127
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Enrollment
Not listed

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2002 (Type not available)
Primary completion
Jan 2003 (Actual)
Completion
Jan 2003 (Actual)
Last update posted
Nov 11, 2013

2002 – 2003

United States locations

U.S. sites
16
U.S. states
11
U.S. cities
16
Facility City State ZIP Site status
Local Institution Anaheim California — —
Local Institution Cerritos California — —
Local Institution Chula Vista California — —
Local Institution Rosemead California — —
Local Institution San Diego California — —
Local Institution Atlanta Georgia — —
Local Institution Macon Georgia — —
Local Instituton Hoffman Estates Illinois — —
Local Institution Las Vegas Nevada — —
Local Institution Nashua New Hampshire — —
Local Institution New York New York — —
Local Institution Beachwood Ohio — —
Local Institution Philadelphia Pennsylvania — —
Local Institution Charleston South Carolina — —
Local Institution Houston Texas — —
Local Institution Milwaukee Wisconsin — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00036127, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 11, 2013 · Synced Nov 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00036127 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →